Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 03 2022
Historique:
entrez: 11 3 2022
pubmed: 12 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

The Canadian Longitudinal Study on Aging (CLSA) Comprehensive cohort was established to provide unique opportunities to study the genetic and environmental contributions to human disease as well as ageing process. The aim of this report was to describe the genomic data included in CLSA. A total of 26 622 individuals from the CLSA Comprehensive cohort of men and women aged 45-85 recruited between 2010 and 2015 underwent genome-wide genotyping of DNA samples collected from blood. Comprehensive quality control metrics were measured for genetic markers and samples, respectively. The genotypes were imputed to the TOPMed reference panel. Sex chromosome abnormalities were identified by copy number profiling. Classical human leukocyte antigen gene haplotypes were imputed at two-field (four-digit). Of the 26 622 genotyped participants, 24 655 (92.6%) were identified as having European ancestry. These genomic data were linked to physical, lifestyle, medical, economic, environmental and psychosocial factors collected longitudinally in CLSA. The combined analysis, including CLSA genomic data, uncovered over 100 novel loci associated with key parameters to define glaucoma. The CLSA genomic dataset validated the contribution of a polygenic risk score to screen individuals with high fracture risk. It is also a valuable resource to directly identify common genetic variations associated with conditions related to complex traits. Taking advantage of the comprehensive interview and physical information collected in CLSA, this genomic dataset has been linked to psychosocial factors to investigate both the independent and interactive effects on cardiovascular disease. The CLSA overall is ongoing. Follow-up data will continue to be collected from participants in the current genomic subcohort, including the DNA methylation and metabolomic data. Ongoing studies focus on elucidating the role of genetic factors in cognitive decline and cardiovascular diseases. This genomic data resource is available on request through the CLSA data access application process.

Identifiants

pubmed: 35273064
pii: bmjopen-2021-059021
doi: 10.1136/bmjopen-2021-059021
pmc: PMC8915305
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e059021

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Epidemiol. 2019 Dec 1;48(6):1752-1753j
pubmed: 31633757
Nat Genet. 2012 Oct;44(10):1090-7
pubmed: 22960999
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Cell. 2019 Mar 21;177(1):200-220
pubmed: 30901541
Can J Aging. 2009 Sep;28(3):221-9
pubmed: 19860977
Nat Rev Genet. 2006 Oct;7(10):781-91
pubmed: 16983374
Am J Hum Genet. 2005 May;76(5):887-93
pubmed: 15789306
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nature. 2021 Feb;590(7845):290-299
pubmed: 33568819
PLoS Genet. 2017 Sep 5;13(9):e1006977
pubmed: 28873402
Am J Hum Genet. 2021 Jul 1;108(7):1204-1216
pubmed: 34077762
Nat Rev Genet. 2020 Feb;21(2):88-101
pubmed: 31690828
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52
pubmed: 11751441
PLoS Med. 2020 Jul 2;17(7):e1003152
pubmed: 32614825
Front Cardiovasc Med. 2021 Mar 16;8:599671
pubmed: 33796568
Bioinformatics. 2015 Mar 1;31(5):782-4
pubmed: 25338720
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Am J Hum Genet. 2016 Mar 3;98(3):456-472
pubmed: 26924531
PLoS Comput Biol. 2013;9(2):e1002877
pubmed: 23459081
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949

Auteurs

Vincenzo Forgetta (V)

Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.

Rui Li (R)

McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Corinne Darmond-Zwaig (C)

McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Alexandre Belisle (A)

McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Cynthia Balion (C)

Hamilton Regional Laboratory Medicine Program, McMaster University, St. Joseph's Hospital St. Luke's Wing, Hamilton, ON, Canada.

Delnaz Roshandel (D)

Genetics & Genomic Biology, The Hospital for Sick Children Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.

Christina Wolfson (C)

Department of Medicine & of Epidemiology and Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.

Guillaume Lettre (G)

Montréal Heart Institute and Université de Montréal, Montréal, QC, Canada.

Guillaume Pare (G)

Hamilton Regional Laboratory Medicine Program, McMaster University, St. Joseph's Hospital St. Luke's Wing, Hamilton, ON, Canada.

Andrew D Paterson (AD)

Genetics & Genomic Biology, The Hospital for Sick Children Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Lauren E Griffith (LE)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Chris Verschoor (C)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Mark Lathrop (M)

McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Susan Kirkland (S)

Department of Community Health and Epidemiology, Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.

Parminder Raina (P)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

J Brent Richards (JB)

Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Department of Medicine & of Epidemiology and Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

Jiannis Ragoussis (J)

McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, QC, Canada ioannis.ragoussis@mcgill.ca.
Department of Human Genetics, McGill University, Montréal, QC, Canada.
Department of Bioengineering, McGill University, Montréal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH